申请人:Pliant Therapeutics, Inc.
公开号:US20180093984A1
公开(公告)日:2018-04-05
The invention relates to compounds of formula (I):
or a salt thereof, wherein R
1
, A, L, and R
2
and n are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are αvβ1 integrin inhibitors that are useful for treating tissue specific fibrosis.